April 10, 2012

Drug, gene and biomarker discovery pilot and feasibility funds application deadline May 14

The Vanderbilt Diabetes Research and Training Center (DRTC) announced a new pilot and feasibility program (P&F) for innovative studies that use the VICB High-Throughput Screening Facility, BioVU or the Mass Spectrometry Research Center for research on diabetes, obesity and metabolism.

The application deadline is Monday, May 14, at 9 a.m. Application forms and detailed instructions can be obtained from the DRTC P&F website: http://www.mc.vanderbilt.edu/diabetes/drtc/pilot2012.php.